Last reviewed · How we verify
NCT05027347
Detection of Plasma Circulating Tumor DNA in Gastric Cancer
trial testing plasma circulating tumor DNA in Circulating Tumor DNA (ctDNA) in 200 participants. Status unknown.
30 September 2023
Quick facts
| Lead sponsor | University Medical Center Ho Chi Minh City (UMC) |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 10 October 2021 |
| Primary completion | 30 September 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across Vietnam |
Drugs / interventions tested
- plasma circulating tumor DNA
Conditions studied
- Circulating Tumor DNA (ctDNA) — all drugs for Circulating Tumor DNA (ctDNA) →
- Gastric Cancer — all drugs for Gastric Cancer →
Sponsor
University Medical Center Ho Chi Minh City (UMC)
Who can join
18 and older, any sex, with Circulating Tumor DNA (ctDNA) or Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to develop a protocol for detection of circulating tumor DNA (ctDNA) in plasma of patients with early stages of gastric cancer.
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
Zhang Z, Wu H, Chong W, Shang L, et al · · 2022 · cited 84× · PMID 36302755 · DOI 10.1038/s41419-022-05350-2 -
Novel biomarkers for early detection of gastric cancer.
Matsuoka T, Yashiro M. · · 2023 · cited 60× · PMID 37213407 · DOI 10.3748/wjg.v29.i17.2515 -
Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy.
Wang X, Wang L, Lin H, Zhu Y, et al · · 2024 · cited 54× · PMID 38333685 · DOI 10.3389/fonc.2024.1303335 -
The Role of ctDNA in Gastric Cancer.
Mencel J, Slater S, Cartwright E, Starling N. · · 2022 · cited 26× · PMID 36291888 · DOI 10.3390/cancers14205105 -
Clinical applications and perspectives of circulating tumor DNA in gastric cancer.
Li JH, Zhang DY, Zhu JM, Dong L. · · 2024 · cited 14× · PMID 38184573 · DOI 10.1186/s12935-024-03209-4 -
Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease-From Early Cancer Detection to Individualized Cancer Treatment.
David P, Mittelstädt A, Kouhestani D, Anthuber A, et al · · 2023 · cited 10× · PMID 37046585 · DOI 10.3390/cancers15071924 -
Next-Generation Sequencing-Based Molecular Profiling Using Cell-Free DNA: A Valuable Tool for the Diagnostic and Prognostic Evaluation of Patients With Gastric Cancer.
Jang MA. · · 2024 · cited 1× · PMID 37880993 · DOI 10.3343/alm.2023.0391
Verify or expand the search:
- PubMed search for NCT05027347
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Medical Center Ho Chi Minh City (UMC) trials
Trials by the same sponsor.
- NCT06768463 — Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer · NA · recruiting
- NCT06595290 — Vietnamese Rapid Acceleration Protocol for Intensifying Drug Therapy in Heart Failure With Reduced Ejection Fraction · NA · recruiting
- NCT07000383 — Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome · NA · recruiting
- NCT07100769 — Application of Real-time Ultrasound Guidance in Thoracic Epidural Catheter Placement · NA · recruiting
- NCT06648720 — Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05027347 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Center Ho Chi Minh City (UMC)
- Last refreshed: 28 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05027347.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing